Effects of Adenosine Receptor Antagonists on the In Vivo LPS-Induced Inflammation Model of Parkinson’s Disease

Por Gołembiowska, Krystyna, Wardas, Jadwiga, Noworyta-Sokołowska, Karolina, Kamińska, Katarzyna, Górska, Anna
Publicado em 2013

Alterations of BDNF and trkB mRNA Expression in the 6-Hydroxydopamine-Induced Model of Preclinical Stages of Parkinson’s Disease: An Influence of Chronic Pramipexole in Rats

Por Berghauzen-Maciejewska, Klemencja, Wardas, Jadwiga, Kosmowska, Barbara, Głowacka, Urszula, Kuter, Katarzyna, Ossowska, Krystyna
Publicado no PLoS One (2015)

Inactivation of neuronal forebrain A(2A) receptors protects dopaminergic neurons in a mouse model of Parkinson’s disease

Por Carta, Anna R, Kachroo, Anil, Schintu, Nicoletta, Xu, Kui, Schwarzschild, Michael A., Wardas, Jadwiga, Morelli, Micaela
Publicado em 2009